Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8657824 | Chest | 2018 | 11 Pages |
Abstract
Metformin use in the initial 2 years was associated with a decreased risk of TB, and metformin users had a reduced risk compared with their sulfonylurea comparators.
Keywords
cDDDLHIDLTBI9th RevisionT2DMICD-9-CMAMPKClinical Modificationchronic kidney diseaseDiabetes mellitusType 2 diabetes mellitusSulfonylureasInternational Classification of Diseaseslatent TB infectionMetforminCKDLongitudinal Health Insurance DatabaseNational Health Insurance Research Databaseadenosine monophosphate-activated protein kinasePrevention
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sheng-Wei MD, Yung-Feng MD, PhD, Yu Ru PhD, Pei-Hung PhD, Vincent Yi-Fong MD, Jia-Yih MD, Yu-Jiun MD, PhD, Wei-Juin MD, MPH,